Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7147)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rastogi P, Sultan M, Charabaty AJ, Atkins MB, Mattar MC. Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital. World J Gastroenterol 2015; 21(14): 4373-4378 [PMID: 25892889 DOI: 10.3748/wjg.v21.i14.4373] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v21/i14/4373.htm |
| Number | Citing Articles |
| 1 |
Ava Bachari, Nazim Nassar, Ellen Schanknecht, Srinivasareddy Telukutla, Terrence Jerald Piva, Nitin Mantri. Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment. WIREs Mechanisms of Disease 2024; 16(1) doi: 10.1002/wsbm.1633
|
| 2 |
Xu Tong, Tao Zhan, Xiaoqin Dong, Dong Xu. Fever of unknown origin associated with immune checkpoint inhibitors. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1364128
|
| 3 |
Nasser M Alorfi, Mansour Marzouq Alourfi. Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis. Biologics: Targets and Therapy 2022; : 119 doi: 10.2147/BTT.S367675
|
| 4 |
Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Aurélien Marabelle, Jean-Marie Michot, Olivier Lambotte, Jérôme Le Pavec, Eleonora De Martin, Corinne Balleyguier, Stéphane Champiat, Samy Ammari. Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1. European Journal of Cancer 2018; 96: 91 doi: 10.1016/j.ejca.2018.03.006
|
| 5 |
Ula Mahadeva. Persisting and emerging areas of diagnostic difficulty in the histopathology of infectious disease of the gastro-intestinal tract. Diagnostic Histopathology 2017; 23(9): 397 doi: 10.1016/j.mpdhp.2017.07.003
|
| 6 |
Yoshito Nishimura, Miho Yasuda, Kazuki Ocho, Masaya Iwamuro, Osamu Yamasaki, Takehiro Tanaka, Fumio Otsuka. Severe Gastritis after Administration of Nivolumab and Ipilimumab. Case Reports in Oncology 2018; 11(2): 549 doi: 10.1159/000491862
|
| 7 |
Caroline Prieux-Klotz, Marie Dior, Diane Damotte, Johann Dreanic, Bertrand Brieau, Catherine Brezault, Vered Abitbol, Stanislas Chaussade, Romain Coriat. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management. Targeted Oncology 2017; 12(3): 301 doi: 10.1007/s11523-017-0495-4
|
| 8 |
Andrew P. Wright, Marc S. Piper, Shrinivas Bishu, Ryan W. Stidham. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor‐induced colitis. Alimentary Pharmacology & Therapeutics 2019; 49(12): 1474 doi: 10.1111/apt.15263
|
| 9 |
Thais Larrainzar-Coghen, Dolors Rodríguez-Pardo, Pere Barba, Juan Aguilar-Company, Virginia Rodríguez, Gloria Roig, Carmen Ferrer, Isabel Ruiz-Camps, Benito Almirante. Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(11): 2075 doi: 10.1007/s10096-018-3341-4
|
| 10 |
Dana Alsaadi, Neil J. Shah, Aline Charabaty, Michael B. Atkins. A case of checkpoint inhibitor-induced celiac disease. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0694-x
|
| 11 |
Roxanna D. Juarez, Andrew Taliaferro, Spencer C. Behr. Functional Imaging of Immunotherapy: Response Criteria, Imaging Characteristics, and Novel Immunoimaging of Advanced Malignancies. Current Radiology Reports 2020; 8(11) doi: 10.1007/s40134-020-00369-9
|
| 12 |
Icilio Cavero, Henry H. Holzgrefe. 18th Annual Meeting of the Safety Pharmacology Society: drug safety assessment on gastrointestinal system functions. Expert Opinion on Drug Safety 2020; 19(1): 19 doi: 10.1080/14740338.2020.1694902
|
| 13 |
Kelcie Witges, Leigh Anne Shafer, Ryan Zarychanski, Ahmed M. Abou-Setta, Rasheda Rabbani, Orvie Dingwall, Charles N. Bernstein. Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis. Drug Safety 2020; 43(12): 1255 doi: 10.1007/s40264-020-00979-4
|
| 14 |
Hampig Raphael Kourie, Jean Klastersky. Immune checkpoint inhibitors side effects and management. Immunotherapy 2016; 8(7): 799 doi: 10.2217/imt-2016-0029
|
| 15 |
Tatsunori Satoh, Kazuya Ohno, Takafumi Kurokami. Endoscopic findings of ipilimumab‐induced colitis. Digestive Endoscopy 2017; 29(3): 388 doi: 10.1111/den.12820
|
| 16 |
B. L. Adler, M. K. Pezhouh, A. Kim, L. Luan, Q. Zhu, F. Gani, M. Yarchoan, J. Chen, L. Voltaggio, A. Parian, M. Lazarev, G. Y. Lauwers, T. M. Pawlik, E. A. Montgomery, E. Jaffee, D. T. Le, J. M. Taube, R. A. Anders. Histopathological and immunophenotypic features of ipilimumab‐associated colitis compared to ulcerative colitis. Journal of Internal Medicine 2018; 283(6): 568 doi: 10.1111/joim.12744
|
| 17 |
Pietro Diana, Charoen Mankongpaisarnrung, Michael B. Atkins, Jay C. Zeck, Aline Charabaty. Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced Enteritis. ACG Case Reports Journal 2018; 5(1): e17 doi: 10.14309/crj.2018.17
|
| 18 |
Aniruddh Som, Rohan Mandaliya, Dana Alsaadi, Maham Farshidpour, Aline Charabaty, Nidhi Malhotra, Mark C Mattar. Immune checkpoint inhibitor-induced colitis: A comprehensive review. World Journal of Clinical Cases 2019; 7(4): 405-418 doi: 10.12998/wjcc.v7.i4.405
|
| 19 |
Hajir Ibraheim, Samantha Baillie, Mark A. Samaan, Hamzah Abu‐Sbeih, Yinghong Wang, Nicholas J. Talley, Michael P. Jones, Nick Powell. Systematic review with meta‐analysis: effectiveness of anti‐inflammatory therapy in immune checkpoint inhibitor‐induced enterocolitis. Alimentary Pharmacology & Therapeutics 2020; 52(9): 1432 doi: 10.1111/apt.15998
|
| 20 |
Yasuo Hamamoto, Natalya Shin, Tomohiro Hoshino, Takanori Kanai. Management of challenging immune-related gastrointestinal adverse events associated with immune checkpoint inhibitors. Future Oncology 2018; 14(30): 3187 doi: 10.2217/fon-2018-0509
|
| 21 |
Liansha Tang, Jialing Wang, Nan Lin, Yuwen Zhou, Wenbo He, Jiyan Liu, Xuelei Ma. Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.800879
|
| 22 |
Kurt Melstrom, Stephen M. Sentovich. Surgical Emergencies in the Cancer Patient. 2017; : 177 doi: 10.1007/978-3-319-44025-5_11
|